GlaxoSmithKline Biologicals SA

Form 483FOIA Uncovered

United StatesIssued May 03, 2023

View FDA's Record for This Firm

Source: Third-party index, not matched to FDA. This record came from a third-party Form 483 index rather than from FDA directly, and we have not been able to match it to a document or an inspection FDA publishes. It stays out of the default view for that reason.

ObservationsNot available

Issue DateMay 03, 2023

StatusWarning Letter Issued

Related Inspections0

Establishment Details

Firm: GlaxoSmithKline Biologicals SA
Location: United States
FEI Number: N/A
Issue Date: May 03, 2023
Country: United States

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

GlaxoSmithKline Biologicals SA FDA Form 483, May 3, 2023